Geneva: Removing intellectual property (IP) protections from COVID-19 vaccines or pressuring companies into technology sharing will not speed up production of the jabs, and could even slow it down, the industry has warned.
Proponents of doing away with IP rights say more companies in more countries could produce the vaccines, providing broader access in poorer nations that so far have seen few doses.
South African President Cyril Ramaphosa, whose country is co-leading a push at the World Trade Organization to exempt COVID-19 vaccines from IP rights, insisted Friday the jabs were a public good and must be recognised as such .
As hopes rise for pandemicâs close, some are preparing for never-ending COVID
Scores of companies, many in Massachusetts, gear up to fight the virus âin perpetuityâ
By Robert Weisman and Jonathan Saltzman Globe Staff,Updated April 24, 2021, 1 hour ago
Email to a Friend
Vaccinations are continuing in Boston at the Harvard Street Neighborhood Health Center clinic at the Prince Hall Grand Lodge. People may need booster shots in the future.Craig F. Walker/Globe Staff
A pandemic-weary public is dreaming of Memorial Day barbecues, summer nights at Fenway Park, and putting the long-running curse of COVID-19 behind us.
But in the medical and biopharma worlds, many are eyeing a more daunting prospect: coronavirus as a never-ending threat.
‘Raw material shortages could hit vaccine supplies’
April 23, 2021
Vaccine-makers pitch for tech-transfers with quality firms
Even as Nobel laureates and public health voices call for a waiver of intellectual property on Covid-19 technologies, including vaccines, global vaccine industry representatives point to export bans as a key barrier to access.
‘Bumpy road ahead’
Collaborations between companies, competitors, countries and regulators has helped deliver multiple Covid-19 vaccines, but the road ahead is “bumpy”, said an industry panel that reflected Big Pharma and companies from the developing world, speaking in a single voice.
On the IP waiver, Sai Prasad, Executive Director, Quality Operations, Bharat Biotech, said that the big picture was to deliver healthcare solutions during the pandemic and that can be done through technology transfer. But then again, technology can be transferred only to companies with the expertise to deliver a quality product, he sai
Biodiesel Magazine - The Latest News and Data About Biodiesel Production biodieselmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biodieselmagazine.com Daily Mail and Mail on Sunday newspapers.
Apr 22, 2021
The Biden administration is weighing an appeal from progressive Democrats to accelerate global access to COVID-19 vaccines, by supporting a waiver of intellectual-property protections a move opposed by big drugmakers.
Lawmakers led by senators Bernie Sanders and Elizabeth Warren called last week on President Joe Biden to back a proposal before the World Trade Organization that seeks a broad waiver from obligations on the protection of intellectual property rights, including patents, copyrights and trade secrets.
The aim is to ease rules regarding the production and export of vaccines and other critical medical goods needed to combat the COVID-19 pandemic.